HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Deeper understanding of disease biology may expand sarcoma treatment options
-
- Lawmakers, technology unite to improve awareness of breast density Christina V. Jacobs, MD
- ASCO announces 2017 fellows class
- Biosimilar candidate B12019 effective for chemotherapy-induced neutropenia
- Foundation Medicine announces participation in NCI-MATCH trial
- Lineberger Comprehensive Cancer Center director to lead NCI
- Muscle mass, density may predict risk for treatment-related toxicities
- Oncologist chosen as American Medical Association’s president-elect
- Seattle Cancer Care Alliance among first to apply multispecialty care approach to kidney cancer
-
- Warren Alpert Foundation recognizes leaders in cancer immunology
- ‘Port-alisib’ and ‘reach-out-to-me-mab’: A novel combination extends OS in a range of cancer types John Sweetenham, MD, FRCP, FACP
- FDA approves Keytruda for advanced urothelial carcinoma
- FDA approves midostaurin for FLT3–mutated AML, other blood disorders
- FDA approves Rebinyn for hemophilia B
- FDA expands approval of Stivarga to include liver cancer
- FDA grants accelerated approval to Keytruda for solid tumors with specific biomarker
- FDA grants breakthrough therapy designation to entrectinib for NTRK fusion–positive solid tumors
-
- FDA grants priority review to copanlisib for follicular lymphoma
- Several agents receive fast track designation
- Adverse events result in high rate of low–molecular-weight heparin discontinuation
- African American genes linked to worse survival in HNSCC
- Androgen deprivation therapy may be linked with dementia in prostate cancer
- Cardiac events common after radiotherapy in NSCLC
- Chemotherapy may not be necessary for intermediate-risk, early-stage breast cancer
- Health-related quality of life remains compromised in young cancer patients 2 years after diagnosis
-
- Online symptom reporting may help patients with cancer live longer
- PSA nadir value following radiation, ADT may predict prostate cancer mortality risk
- Routine imaging does not significantly improve OS in relapsed DLBCL
- Survivors of Hodgkin lymphoma have increased risk for second cancer
- Abemaciclib with fulvestrant effective in advanced breast cancer subtype
- Addition of abiraterone to androgen deprivation reduces risk for death in advanced prostate cancer
- Carl H. June, MD, receives ASCO’s highest scientific honor
- Combined immune checkpoint blockade shows promise for small cell lung cancer
-
- Exercise may decrease women’s risk for breast cancer
- Genomic testing may guide personalized care for advanced cancer
- Induction triplets comparably effective, safe for newly diagnosed myeloma
- Larotrectinib exhibits durable activity in adults, children with various cancers
- Lenalidomide plus rituximab elicits favorable response in follicular lymphoma
- Nivolumab plus ipilimumab active for melanoma brain metastases
- Nut consumption reduces risk for colon cancer recurrence
- Web-based stress management program improves quality of life for patients with cancer
-
- Should young patients with rare sarcoma subtypes be included in adult sarcoma trials?